Fit for health 2.0, introduction to H2020
Upcoming SlideShare
Loading in...5
×
 

Fit for health 2.0, introduction to H2020

on

  • 564 vues

Fit for health 2.0, introduction to H2020

Fit for health 2.0, introduction to H2020
Presentation done durin the H2020 infoday at Institut Pasteur de Tunis, may, 15, 2014

Statistics

Vues

Total Views
564
Views on SlideShare
332
Embed Views
232

Actions

Likes
0
Downloads
7
Comments
0

2 Ajouts 232

http://www.scoop.it 227
http://news.google.com 5

Accessibilité

Détails de l'import

Uploaded via as Adobe PDF

Droits d'utilisation

© Tous droits réservés

Report content

Signalé comme inapproprié Signaler comme inapproprié
Signaler comme inapproprié

Indiquez la raison pour laquelle vous avez signalé cette présentation comme n'étant pas appropriée.

Annuler
  • Full Name Full Name Comment goes here.
    Are you sure you want to
    Votre message apparaîtra ici
    Processing...
Poster un commentaire
Modifier votre commentaire

Fit for health 2.0, introduction to H2020 Fit for health 2.0, introduction to H2020 Presentation Transcript

  • Introduction to Horizon 2020 15.05.2014 | TUNIS Nicolas Villacorta | Management Jülich dr Frank Heemskerk
  • 15.052014 TUNIS Introduction to Horizon 2020 EU Funding for Research and Innovation Driven by EU politics (Europe 2020 Strategy) Funding of single researchers and research consortia Pool and exchange knowlegde and experience Projects with partners from different disciplines and sectors EU funding based on subsidy principle Funding from basic research to close-to- market activities Enhance your reputation Compare your achievements on international level Collaboration with partners in Europe and beyond 2 © Fit for Health 2.0, 2014
  • 15.052014 TUNIS Introduction to Horizon 2020 Overview of Horizon 2020  Public largest international, competitive, cooperative Research & Innovation Programme for the period 2014-2020  Leading instrument for the implementation of the European Research Area  Specific programme: pre-defined thematic areas  Supports competitiveness in Europe  Beyond Europe: International Cooperation HORIZON 2020 3 © Fit for Health 2.0, 2014
  • 15.052014 TUNIS Introduction to Horizon 2020 New in Horizon 2020  A single programme bringing together three separate programmes/initiatives: FP7 + CIP + EIT*  More innovation: from research to commercialisation of all forms of innovation  Focus on societal challenges faced by EU society including health, food security, clean energy and transport  Simplified access for all companies, universities, institutes in all EU countries and beyond. * The 7th research Framework Programme (FP7), innovation aspects of Competitiveness and Innovation Framework Programme (CIP), EU contribution to the European Institute of Innovation and Technology (EIT) 4 © Fit for Health 2.0, 2014
  • 15.052014 TUNIS Introduction to Horizon 2020 Structure of Horizon 2020 Source: www.eubuero.de. Simplified nomenclature I. Excellent Science II. Industrial Leadership III. Societal Challenges LEIT Leadership in Enabling and Industrial Technologies: ICT, Nanotechnology, Advanced Materials, Biotechnology, Production Technology, Space Access to Risk Finance Innovation in SMEs ERC FET Marie-Skłodowska- Curie Infrastructures JRC EIT Health, Demographic Change and Wellbeing Challenges in the European Bioeconomy… Secure, clean and efficient Energy Smart, green and integrated transport Climate, environment, resource efficiency & raw materials Integrative, innovative and reflective societies Secure societies Spreading Excellence Widening Participation Science with and for Society 5 © Fit for Health 2.0, 2014
  • 15.052014 TUNIS Introduction to Horizon 2020 "direct“ Activities (JRC, nuclear) + SpecificProgramme Cooperation People Ideas Capacities Joint Research Centre (JRC, not nuclear) "indirect" Activities (Fusion, Fission and radiation protection) Framework Programme EURATOM Source: www.eubuero.de 7th Framework Programme 6 © Fit for Health 2.0, 2014
  • 15.052014 TUNIS Introduction to Horizon 2020 Horizon 2020 – 7th Framework Programme FP7 I. Excellent Science II. Industrial Leadership III. Societal Challenges LEIT ICT, Nano- technology, Materials, Biotechnology, Production technologies, Space Risk Finance Innovation in SMEs ERC FET MSC INFRA JRC EIT Health, DC & WB Bioeconomy Energy Transport Environment, raw materials Societies Security Spreading Excellence Widening Participation Science with and for Society ERC Marie Curie KBBE Cooperation People Ideas Capacities JRC (no nuclear) HEALTH KBBE Source: www.eubuero.de. Simplified nomenclature 7 © Fit for Health 2.0, 2014
  • 15.052014 TUNIS Introduction to Horizon 2020 Source: www.eubuero.de. Budgetary Breakdown (EUR) 31.3% 22.09% 38.53% 1.06% 0.60% 3.52% 2.47% Excellent Science Industrial Leadership Societal Challenges Widening Participation Science with and for Society JRC EIT 29.7 bn 24.4 bn. 17 bn. 1.9 bn. 2.7 bn. 0.8 bn. 0.4 bn. For 2014-2020 : 77.0 bn. EUR (23 561 bn. HUF) 8 © Fit for Health 2.0, 2014
  • 15.052014 TUNIS Introduction to Horizon 2020 Source: www.eubuero.de Terminology in Horizon 2020 II. Industrial Leadership LEIT Leadership in Enabling and Industrial Technologies ICT, Nanotechnology, Biotechnology… Part II, Priority Specific Objective Activity Line Topic(s) Next generation Computers: Advanced calculation systems and technologies, including Cloud Computing 9 © Fit for Health 2.0, 2014
  • 15.052014 TUNIS Introduction to Horizon 2020 I. Excellent Science Objectives:  Reinforce and widen excellence in science  Consolidate the European Research Area  Increase the global competitiveness of the research and innovation system in Europa Trends:  Science-driven projects  „bottom-up“  Possibility of cofunding from member states  Researchers set the research agenda * FET = Future and Emerging Technologies I. Excellent Science ERC FET Marie-Skłodowska- Curie Infrastructures 10 © Fit for Health 2.0, 2014
  • 15.052014 TUNIS Introduction to Horizon 2020 European Research Council (ERC) I. Excellent Science ERC FET Marie-Skłodowska- Curie Infrastructures  Total budget: 11.9 bn. EUR  Starting Grants 2-7 years after PhD, up to 2 m. EUR for max. 5 years  Consolidator Grants 7-12 years after PhD, up to 2.75 m. EUR for max. 5 years  Advanced Grants for experienced and excellent researchers, up to 3.5 m EUR for max. 5 years  Synergy Grants for consortia from two to four excellent researchers, up to 15 m EUR for max. 6 years  Proof-of-Concept for ERC Grantees to implement the innovation dimension of a idea, (0.15 m. EUR)NCP-ERC 11 © Fit for Health 2.0, 2014
  • 15.052014 TUNIS Introduction to Horizon 2020 Future and Emerging Technologies (FET) I. Excellent Science ERC FET Marie-Skłodowska- Curie Infrastructures  Total budget: 2.5 bn. EUR  Cutting-edge research in new Technologies  FET Open: • Theme open, early research in technologies through cooperative projects  FET Proactive: • Specific Funding for new themes • Support for research clusters • Setting of Communities  FET Flagship: • Design of a research agenda • Research initiatives in a think-big dimension: so far GRAPHENE und Human Brain Project Source: www.eubuero.de NCP-FET 12 © Fit for Health 2.0, 2014
  • 15.052014 TUNIS Introduction to Horizon 2020 SME SME SME Marie Skłodowska-Curie Actions (MSCA) I. Excellent Science ERC FET Marie-Skłodowska- Curie Infrastructures  Total budget: 5.6 m. EUR  Action 1: Innovative Training Networks (ITN) Training for PhDs  Action 2: Individual Fellowships (IF) Funding for experienced researchers (post-doc)  Action 3: Research and Innovation Staff Exchange (RISE) Exchange of staff within cooperation projects  Action 4: COFUND Mechanism of co-funding for (national) mobility programmes NCP-MOBILITY 13 © Fit for Health 2.0, 2014
  • 15.052014 TUNIS Introduction to Horizon 2020 Infrastructures I. Excellent Science ERC FET Marie-Skłodowska- Curie Infrastructures Source: www.eubuero.de  Total budget: 2.3 m. EUR Objectives:  Integration existent research infrastructures  Construction of new research organisations and facilities of common european interest  Funding instrument: Combination of cooperation projects and coordination and support actions NCP-INFRA 14 © Fit for Health 2.0, 2014
  • 15.052014 TUNIS Introduction to Horizon 2020 II. Industrial Leadership LEIT Leadership in Enabling and Industrial Technologies: ICT, Nanotechnology, Advanced Materials, Biotechnology, Production Technology, Space Access to Risk Finance Innovation in SMEs II. Industrial Leadership Source: www.eubuero.de Objectives:  Fast-track development of technologies and innovation  Key Enabling Technologies: KET  Fundamentals of tomorrow‘s business  Support of innovative european SMEs Trends:  Industrial strategic agendas dictate the calls  Close-to-market activities  Adapted conditions  Industry with a key role 15 © Fit for Health 2.0, 2014
  • 15.052014 TUNIS Introduction to Horizon 2020 II. Industrial Leadership LEIT Leadership in Enabling and Industrial Technologies: ICT, Nanotechnology, Advanced Materials, Biotechnology, Production Technology, Space Access to Risk Finance Innovation in SMEs KET Biotechnology NCP-BIO Workprogramme of KET Biotech  Five topics for 2014-2015  Support of cutting-edge biotechnologies as future innovative force  Industrial biotechnology  Innovative and competitive technology platforms 16 © Fit for Health 2.0, 2014
  • 15.052014 TUNIS Introduction to Horizon 2020 II. Industrial Leadership LEIT Leadership in Enabling and Industrial Technologies: ICT, Nanotechnology, Advanced Materials, Biotechnology, Production Technology, Space Access to Risk Finance Innovation in SMEs KET Nanotechnology: Nanomedicine NCP-NMP Section „Nanotechnology and Advanced Materials for a more effective Healthcare“:  Enable more effective therapies and diagnostics through nanotechnologies and advanced materials  Clinical tests of new developments are foreseen  Industry including SMEs are key players 17 © Fit for Health 2.0, 2014
  • 15.052014 TUNIS Introduction to Horizon 2020 II. Industrial Leadership LEIT Leadership in Enabling and Industrial Technologies: ICT, Nanotechnology, Advanced Materials, Biotechnology, Production Technology, Space Access to Risk Finance Innovation in SMEs Access to Risk Finance NCP-FINANCE  Financial Instruments: • Loans Service for R&I • SMEs & Small Midcaps R&I Loans Service • Equity Facility for R&I • Technology Transfer Financing Facility Pilot  External Expertise: • Assessing the Investment Potential of SMEs Emerging from Phase I of the SME Instrument • Technical and Financial Advisory Service for Risk Finance in R&I  Studies: • Understanding the Intellectual Property Aggregation Marketplace • Understanding the Nature and Impact of Angel and Crowd- Funding in R&I • … http://access2eufinance.ec.europa.eu/ 18 © Fit for Health 2.0, 2014
  • 15.052014 TUNIS Introduction to Horizon 2020 II. Industrial Leadership LEIT Leadership in Enabling and Industrial Technologies: ICT, Nanotechnology, Advanced Materials, Biotechnology, Production Technology, Space Access to Risk Finance Innovation in SMEs Innovation in SMEs  Aim: close the gap for early phases of high risk research and innovation  Broad meaning of innovation: technological and non-technological, social and service innovation (European added-value)  Implementation: Reference to topics with SME instrument in other programmes NCP-SME 19 © Fit for Health 2.0, 2014
  • 15.052014 TUNIS Introduction to Horizon 2020 III. Societal Challenges Source: www.eubuero.de Objectives:  Alignement to political Focus (Strategy EU 2020)  Complete cycle from research to commercialisation. Focus on innovation  Bild critical mass – transdisciplinary research Trends:  Tight collaboration with other DGs during design of workprogramme  Coordination and completion with ERA-Nets and JPIs – Mobilisation of complementary funding for research and innovation  Focus on 7 areas (Societal Challenges)  Coverage of the complete innovation chain: research, technological development, demonstration and innovation activities III. Societal Challenges Health, Demographic Change and Wellbeing Challenges in the European Bioeconomy… Secure, clean and efficient Energy Smart, green and integrated transport Climate, environment, resource efficiency & raw materials Integrative, innovative and reflective societies Secure societies 20 © Fit for Health 2.0, 2014
  • 15.052014 TUNIS Introduction to Horizon 2020 III. Societal Challenges Source: www.eubuero.de Objectives:  Alignement to political Focus (Strategy EU 2020)  Complete cycle from research to commercialisation. Focus on innovation  Bild critical mass – transdisciplinary research Trends:  Tight collaboration with other DGs during design of workprogramme  Coordination and completion with ERA-Nets and JPIs – Mobilisation of complementary funding for research and innovation  Focus on 7 areas (Societal Challenges)  Coverage of the complete innovation chain: research, technological development, demonstration and innovation activities III. Societal Challenges Health, Demographic Change and Wellbeing Challenges in the European Bioeconomy… Secure, clean and efficient Energy Smart, green and integrated transport Climate, environment, resource efficiency & raw materials Integrative, innovative and reflective societies Secure societies NCP-HEALTH 21 © Fit for Health 2.0, 2014
  • 15.052014 TUNIS Introduction to Horizon 2020 Participation of SMEs  Integrated approach - around 20% of the total budget for societal challenges and LEITs to go to SMEs  Simplification of particular benefit to SMEs (e.g. single entry point)  A new SME instrument, building on the SBIR model, will be used across all societal challenges as well as for the LEITs  'Access to risk finance' will have a strong SME focus (debt and equity facility) 22 © Fit for Health 2.0, 2014
  • 15.052014 TUNIS Introduction to Horizon 2020 Horizon 2020: Societal Challenges (SCs)  Societal Challenges: Addressing key societal challenges (climate, energy, transport etc) through multi-disciplinary applied research including social sciences & humanities Health, demographic change & wellbeing 7 472 Mio € (current prices) Food security, sustainable agriculture & forestry, marine & maritime & inland water research & the Bioeconomy 3 851 Mio € Secure, clean & efficient energy * 5 931 Mio € Smart, green & integrated transport 6 339 Mio € Climate action, environment, resource efficiency & raw materials 3 081 Mio € Inclusive, innovative & reflective societies 1 310 Mio € Secure societies 1 695 Mio € 23 © Fit for Health 2.0, 2014
  • 15.052014 TUNIS Introduction to Horizon 2020 SC1 Work Programme: Structure 1. Personalising Health & Care (PHC)  1.1. Understanding health, ageing & disease  1.2. Effective health promotion, disease prevention, preparedness & screening  1.3. Improving diagnosis  1.4. Innovative treatments & technologies  1.5. Advancing active & healthy ageing  1.6. Integrated, sustainable, citizen-centred care  1.7. Improving health information, data exploitation & providing an evidence base for health policies & regulation 2. Health Co-ordination activities (HCO) 3. Health Other Actions (HOA) 24 © Fit for Health 2.0, 2014
  • 15.052014 TUNIS Introduction to Horizon 2020 SC1 Work Programme 2014-2015 Call ‘Personalising Health & Care - PHC‘ 34 topics (15 open in 2014, 17 in 2015, 2 in 2014 & 2015) Call ‘Health Co-ordination Activities - HCO‘ 16 topics (11 open in 2014, 5 in 2015) 1,21 billion € http://ec.europa.eu/research/participants/portal/doc/call/h2020/ common/1587763-08._health_wp2014-2015_en.pdf 25 © Fit for Health 2.0, 2014
  • 15.052014 TUNIS Introduction to Horizon 2020 SC1 Work Programme 2014-2015: Example of Call’s Topic  'PHC 2 – 2015'  'Specific challenge'  'Scope'  'Expected impact'  'Type of action' 26 © Fit for Health 2.0, 2014
  • 15.052014 TUNIS Introduction to Horizon 2020 SC1 Work Programme 2014-2015: Call PHC - Area 1 AREA TOPIC / YEAR ACTION BUDGET 1 or 2 STAGES 1.1 Understanding health, ageing & disease PHC 1 – 2014: Understanding health, ageing & disease: determinants, risk factors & pathways (4-6 Mio €) RIA (100%) 54 Mio. € 2 stages PHC 2 – 2015: Understanding diseases: systems medicine (4-6 Mio €) RIA (100%) 36 Mio. € 2 stages PHC 3 - 2015: Understanding common mechanisms of diseases & their relevance in co-morbidities (4-6 Mio €) RIA (100%) 30 Mio. € 2 stages 27 © Fit for Health 2.0, 2014
  • 15.052014 TUNIS Introduction to Horizon 2020 SC1 Work Programme 2014-2015: Call PHC – Area 2 AREA TOPIC / YEAR ACTION BUDGET 1 or 2 ST 1.2 Effective health promotion, disease prevention, preparedness & screening PHC 4–2015: Health promotion & disease prevention: improved inter-sector co-operation for environment & health based interventions (4-6 Mio €) RIA (100%) 18 Mio. € 2 stages PHC 5–2014: Health promotion and disease prevention: translating ‘omics’ into stratified approaches (4-6 Mio €) RIA (100%) 24 Mio. € 2 stages PHC 6–2014: Evaluating existing screening and prevention programmes (2-3 Mio €) RIA (100%) 15 Mio. € 2 stages PHC 7–2014: Improving the control of infectious epidemics & foodborne outbreaks through rapid identification of pathogens (see also SC2) (15-20 Mio €) RIA (100%) 20 Mio. € (15 SC1 +5 SC2) 1 stage & hearing PHC 8–2014: Vaccine development for poverty- related and neglected infectious diseases: Tuberculosis (15-20 Mio €) RIA (100%) 25 Mio. € 1 stage & hearing PHC 9–2015: Vaccine development for poverty- related and neglected infectious diseases: HIV/AIDS (15-20 Mio €) RIA (100%) 21 Mio. € 1 stage & hearing 28 © Fit for Health 2.0, 2014
  • 15.052014 TUNIS Introduction to Horizon 2020 SC1 Work Programme 2014-2015: Call PHC – Area 3 AREA TOPIC / YEAR ACTION BUDGET 1 or 2 ST 1.3 Improving diagnosis PHC 10 – 2014: Development of new diagnostic tools and technologies: in vitro devices, assays and platforms (4-6 Mio €) RIA (100%) 48 Mio. € 2 stages PHC 11 – 2015: Development of new diagnostic tools and technologies: in vivo medical imaging technologies (4-6 Mio €) RIA (100%) 47 Mio. € 2 stages PHC 12 – 2014/2015: Clinical research for the validation of biomarkers and/or diagnostic medical devices (50000 € phase 1; 2-5 Mio € phase 2) SME (100%) 66.10 Mio. € (2014)+ 45 Mio. € (2015) (*10% phase 1; 88% phase 2; 2% phase 3) Single stage – 2 cut off dates 29 © Fit for Health 2.0, 2014
  • 15.052014 TUNIS Introduction to Horizon 2020 SC1 Work Programme 2014-2015: Call PHC – Area 4 AREA TOPIC / YEAR ACTION BUDGET 1 or 2 ST 1.4 Innovative treatments & technologies PHC 13 – 2014: New therapies for chronic non- communicable diseases (4-6 Mio €) RIA (100%) 60 Mio. € 2 stages PHC 14 – 2015: New therapies for rare diseases (4-6 Mio €) RIA (100%) 60 Mio. € 2 stages PHC 15 – 2014/2015: Clinical research on regenerative medicine (4-6 Mio €) RIA (100%) 71 Mio. € (36 (2014)+ 35 (2015)) 1 stage 2014 PHC 16 – 2015: Tools and technologies for advanced therapies (4-6 Mio €) RIA (100%) 36 Mio. € 2 stages PHC 17 – 2014: Comparing the effectiveness of existing healthcare interventions in the elderly (4-6 Mio €) RIA (100%) 48 Mio. € 2 stages PHC 18 – 2015: Establishing effectiveness of health care interventions in the paediatric population (4-6 Mio €) RIA (100%) 26 Mio. € 2 stages 30 © Fit for Health 2.0, 2014
  • 15.052014 TUNIS Introduction to Horizon 2020 SC1 Work Programme 2014-2015: Call PHC – Area 5 AREA TOPIC / YEAR ACTION BUDGET 1 or 2 ST 1.5 Advancing active & healthy ageing PHC 19–2014: Advancing active & healthy ageing with ICT: Service robotics within assisted living environments (3-4 Mio €) RIA (100%) 24.6 Mio.€ 1 stage PHC 20–2014: Advancing active & healthy ageing with ICT: ICT solutions for independent living with cognitive impairment (2-3 Mio €) IA (70%) 10 Mio. € 1 stage PHC 21–2015: Advancing active and healthy ageing with ICT: Early risk detection and intervention (3-4 Mio €) RIA (100%) 21 Mio. € 1 stage PHC 22–2015: Promoting mental wellbeing in the ageing population (4-6 Mio €) RIA (100%) 17 Mio. € 2 stages 31 © Fit for Health 2.0, 2014
  • 15.052014 TUNIS Introduction to Horizon 2020 SC1 Work Programme 2014-2015: Call PHC – Area 6 AREA TOPIC / YEAR ACTION BUDGET 1 or 2 ST 1.6 Integrated, sustainable, citizen-centred care PHC 23–2014: Developing and comparing new models for safe and efficient, prevention oriented health and care systems (4-6 Mio €) RIA (100%) 30 Mio.€ 2 stages PHC 24–2015: Piloting personalised medicine in health and care systems (12-15 Mio €) RIA (100%) 30 Mio. € 2 stages PHC 25 – 2015: Advanced ICT systems and services for Integrated Care (3-5 Mio €) RIA (100%) 20 Mio. € 1 stage PHC 26–2014: Self-management of health and disease: citizen engagement and mHealth (3-5 Mio €) RIA (100%) 59.6 Mio. € 1 stage PHC 27–2015: Self-management of health & disease & patient empowerment supported by ICT (3-5 Mio €) PCP 15 Mio. € 1 stage PHC 28–2015: Self-management of health & disease & decision support systems based on predictive computer modelling used by the patient him or herself (3-5 Mio €) RIA (100%) 20 Mio. € 1 stage PHC 29–2015: Public procurement of innovative eHealth services (1-5 Mio €) PPI 10 Mio. € 1 stage 32 © Fit for Health 2.0, 2014
  • 15.052014 TUNIS Introduction to Horizon 2020 SC1 Work Programme 2014-2015: Call PHC – Area 7 AREA TOPIC / YEAR ACTION BUDGET 1 or 2 ST 1.7 Improving health information, data exploitation & providing an evidence base for health policies & regulation PHC 30–2015: Digital representation of health data to improve disease diagnosis and treatment (3-5 Mio €) RIA (100%) 20 Mio.€ 1 stage PHC 31–2014: Foresight for health policy development & regulation (2-3 Mio €) RIA (100%) 6 Mio. € 1 stage PHC 32–2014: Advancing bioinformatics to meet biomed &clinical needs (2-3 Mio €) RIA (100%) 24 Mio. € 2 stages PHC 33–2015: New approaches to improve predictive human safety testing (10-15 Mio €) RIA (100%) 30 Mio. € 2 stages PHC 34–2014: eHealth interoperability (up to 1 Mio €) CSA (100%) 4 Mio. € 1 stage 33 © Fit for Health 2.0, 2014